Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Malka Brodsky"'
Autor:
Renata Faermann, Eitan Friedman, Orit Kaidar-Person, Jonathan Weidenfeld, Malka Brodsky, Anat Shalmon, Osnat Halshtok Neiman, Michael Gotlieb, Yael Yagil, David Samoocha, Dana Madorsky Feldman, Miri Sklair-Levy
Publikováno v:
The Breast Journal, Vol 2022 (2022)
Background. While BRCA1/BRCA2 pathogenic sequence variants (PSVs) clearly confer an increased risk for invasive breast cancer, the extent to which these mutant alleles increase DCIS risk is less clear. Objective. To assess the rate of detection over
Externí odkaz:
https://doaj.org/article/7dc68ee49731443b9eddc59a44b28de5
Autor:
Keren Bahar‐Shany, Georgina D. Barnabas, Lisa Deutsch, Netanel Deutsch, Efrat Glick‐Saar, Dan Dominissini, Stav Sapoznik, Limor Helpman, Tamar Perri, Anna Blecher, Guy Katz, Itai Yagel, Orgad Rosenblatt, Daniel Shai, Benny Brandt, Raanan Meyer, Aya Mohr‐Sasson, Alexander Volodarsky‐Perel, Itamar Zilberman, Shunit Armon, Ariella Jakobson‐Setton, Ram Eitan, Yfat Kadan, Mario Beiner, Dana Josephy, Malka Brodsky, Eitan Friedman, Liat Anafi, Yossef Molchanov, Jacob Korach, Tamar Geiger, Keren Levanon
Publikováno v:
International journal of cancerREFERENCES. 152(4)
No current screening methods for high-grade ovarian cancer (HGOC) guarantee effective early detection for high-risk women such as germline BRCA mutation carriers. Therefore, the standard-of-care remains risk-reducing salpingo-oophorectomy (RRSO) arou
Autor:
Renata Faermann, Eitan Friedman, Orit Kaidar-Person, Jonathan Weidenfeld, Malka Brodsky, Anat Shalmon, Osnat Halshtok Neiman, Michael Gotlieb, Yael Yagil, David Samoocha, Dana Madorsky Feldman, Miri Sklair-Levy
Publikováno v:
The breast journal. 2022
Background. While BRCA1/BRCA2 pathogenic sequence variants (PSVs) clearly confer an increased risk for invasive breast cancer, the extent to which these mutant alleles increase DCIS risk is less clear. Objective. To assess the rate of detection over
Autor:
Renata Faermann, Eitan Friedman, Orit Kaidar-Person, Malka Brodsky, Osnat Halshtok Neiman, Anat Shalmon, Michael Gotlieb, Yael Yagil, David Samocha, Dana Madorsky Feldman, Jonathan Weidenfeld, Miri Sklair-Levy
Publikováno v:
Academic radiology.
Female carriers of pathogenic sequence variants (PSVs) in the BRCA1 /BRCA2 (Breast Cancer gene - BRCA) genes are at a substantially high-risk for developing breast cancer (BC), hence are offered active surveillance scheme based on semiannual breast e
Autor:
Edna Furman-Haran, Ilana Haas, Osnat Halshtok-Neiman, Shani Paluch-Shimon, Noam Nissan, Tehillah Menes, Tanir M. Allweis, Varda Kent, Eli Konen, Anat Shalmon, Daphna Barsuk, Miri Sklair-Levy, Renata Faermann, Liat Friedman Granot, Michael Gotlieb, Asia Bordsky, Malka Brodsky, Orit Golan
Publikováno v:
Journal of Magnetic Resonance Imaging. 49:508-517
BACKGROUND Pregnancy-associated breast cancer (PABC) is often a delayed diagnosis and contrast-enhanced MRI is contraindicated because gadolinium agents are known to cross the placenta. PURPOSE To investigate the feasibility and clinical utility of n
Autor:
Tanir M. Allweis, Shani Paluch-Shimon, Anat Shalmon, Debbie Anaby, Michael Gotlieb, Eli Konen, Ilana Haas, Yaheli Miller, Malka Brodsky, Orit Golan, Einat Carmon, Noam Nissan, Renata Faermann, Miri Sklair-Levy, Philip Lawson, Tehillah Menes, Hani Barlev, Asia Brodsky, Osnat Halshtok-Neiman
Publikováno v:
European radiology. 30(2)
To investigate the effect of lactation on breast cancer conspicuity on dynamic contrast-enhanced (DCE) MRI in comparison with diffusion tensor imaging (DTI) parametric maps. Eleven lactating patients with 16 biopsy-confirmed pregnancy-associated brea
Autor:
Noam, Nissan, Edna, Furman-Haran, Tanir, Allweis, Tehillah, Menes, Orit, Golan, Varda, Kent, Daphna, Barsuk, Shani, Paluch-Shimon, Ilana, Haas, Malka, Brodsky, Asia, Bordsky, Liat Friedman, Granot, Osnat, Halshtok-Neiman, Renata, Faermann, Anat, Shalmon, Michael, Gotlieb, Eli, Konen, Miri, Sklair-Levy
Publikováno v:
Journal of magnetic resonance imaging : JMRI. 49(2)
Pregnancy-associated breast cancer (PABC) is often a delayed diagnosis and contrast-enhanced MRI is contraindicated because gadolinium agents are known to cross the placenta.To investigate the feasibility and clinical utility of noncontrast breast MR